PuraPharm Corporation Limited (HKG:1498)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2440
-0.0060 (-2.40%)
Sep 18, 2026, 2:08 PM HKT

PuraPharm Corporation Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
323.49336.11382.09406.86448.07659.59
Revenue Growth
-3.75%-12.03%-6.09%-9.20%-32.07%9.60%
Gross Profit
177.35180.16205.14216.63262.7423.35
Operating Income
-8.12-16.22-18.25-53.2-68.2515.14
Net Income
-27.66-35.22-35.44-106.08-120.21-121.88
Earnings Per Share
-0.06-0.08-0.09-0.27-0.30-0.31
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Hong Kong CCMG
209.86204.95212.49215.47199.41170.64
Clinics
50.0151.2456.3153.7346.1150.03
Elimination
-192.01-193.01-156.59-156.33-208.51-136.05
Chinese Healthcare Products
84.8196.9785.9183.5879.2879.09
Plantation
-175.97183.9837.6189.5344.83
Total
323.49336.11382.09406.86448.07659.59

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
12.2335.936.942.9891.3696.06
Total Debt
370.62351.14363.76424.77503.16531.96
Net Cash (Debt)
-358.39-315.25-326.86-381.8-411.8-435.9
Net Cash Growth
------
Net Cash Per Share
-0.73-0.75-0.83-0.97-1.04-1.11

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.7228.53103.9979.6188.51-14.52
Capital Expenditures
-1.76-0.28-14.81-19.18-20.83-3.09
Free Cash Flow
-6.4828.2489.1860.4367.68-17.61
Free Cash Flow Growth
--68.33%47.58%-10.72%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.82%53.60%53.69%53.24%58.63%64.18%
Operating Margin
-2.51%-4.83%-4.78%-13.08%-15.23%2.30%
Pretax Margin
-8.60%-10.24%-7.63%-25.15%-26.60%-17.77%
Profit Margin
-8.55%-10.48%-9.28%-26.07%-26.83%-18.48%
FCF Margin
-2.00%8.40%23.34%14.85%15.10%-2.67%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.3313.3313.3313.3313.33
P/FCF Ratio
-6.732.445.887.47-
PS Ratio
0.400.560.570.871.130.48